176 related articles for article (PubMed ID: 25352845)
1. Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis.
Murphy AJ; Dragoljevic D; Tall AR
Front Immunol; 2014; 5():490. PubMed ID: 25352845
[TBL] [Abstract][Full Text] [Related]
2. Regulation and consequences of monocytosis.
Dutta P; Nahrendorf M
Immunol Rev; 2014 Nov; 262(1):167-78. PubMed ID: 25319334
[TBL] [Abstract][Full Text] [Related]
3. Myeloid cells regulate plasma LDL-cholesterol levels.
Bazioti V; La Rose AM; Westerterp M
Curr Opin Lipidol; 2018 Jun; 29(3):233-239. PubMed ID: 29601312
[TBL] [Abstract][Full Text] [Related]
4. Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis.
Chen FY; Zhou J; Guo N; Ma WG; Huang X; Wang H; Yuan ZY
Biochem Biophys Res Commun; 2015 Nov; 467(4):872-8. PubMed ID: 26471308
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Phenotype and Function in Different Stages of Atherosclerosis.
Tabas I; Bornfeldt KE
Circ Res; 2016 Feb; 118(4):653-67. PubMed ID: 26892964
[TBL] [Abstract][Full Text] [Related]
6. Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesis.
Dragoljevic D; Westerterp M; Veiga CB; Nagareddy P; Murphy AJ
Clin Sci (Lond); 2018 Sep; 132(17):1889-1899. PubMed ID: 30185612
[TBL] [Abstract][Full Text] [Related]
7. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
8. Lifestyle effects on hematopoiesis and atherosclerosis.
Nahrendorf M; Swirski FK
Circ Res; 2015 Feb; 116(5):884-94. PubMed ID: 25722442
[TBL] [Abstract][Full Text] [Related]
9. HDL does not influence the polarization of human monocytes toward an alternative phenotype.
Colin S; Fanchon M; Belloy L; Bochem AE; Copin C; Derudas B; Stroes ES; Hovingh GK; Kuivenhoven JA; Dallinga-Thie GM; Staels B; Chinetti-Gbaguidi G
Int J Cardiol; 2014 Mar; 172(1):179-84. PubMed ID: 24456889
[TBL] [Abstract][Full Text] [Related]
10. Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis.
Flynn MC; Pernes G; Lee MKS; Nagareddy PR; Murphy AJ
Front Pharmacol; 2019; 10():666. PubMed ID: 31249530
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.
Westerterp M; Van Eck M; de Haan W; Offerman EH; Van Berkel TJ; Havekes LM; Rensen PC
Atherosclerosis; 2007 Nov; 195(1):e9-16. PubMed ID: 17320883
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.
Cochain C; Koch M; Chaudhari SM; Busch M; Pelisek J; Boon L; Zernecke A
Circ Res; 2015 Jul; 117(3):244-53. PubMed ID: 25991812
[TBL] [Abstract][Full Text] [Related]
13. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
[TBL] [Abstract][Full Text] [Related]
14. Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis.
Fadini GP; Simoni F; Cappellari R; Vitturi N; Galasso S; Vigili de Kreutzenberg S; Previato L; Avogaro A
Atherosclerosis; 2014 Dec; 237(2):805-8. PubMed ID: 25463124
[TBL] [Abstract][Full Text] [Related]
15. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
18. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
[TBL] [Abstract][Full Text] [Related]
19. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice.
Combadière C; Potteaux S; Rodero M; Simon T; Pezard A; Esposito B; Merval R; Proudfoot A; Tedgui A; Mallat Z
Circulation; 2008 Apr; 117(13):1649-57. PubMed ID: 18347211
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice.
Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M
Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
